About us
Impact and scope
La Fondation Québécoise du Sida is a non-profit fundraising organization founded in 1989 by COCQ-SIDA (Coalition des organismes communautaires québécois de lutte contre le Sida) and Coalition Plus (Coalition internationale d’ONG de lutte contre le Sida, co-founded by la COCQ-SIDA).
The Foundation actively participates in the funding of 19 member organizations across Quebec, which work on a daily basis with people living with HIV/AIDS, as well as with the general public in missions to inform and raise awareness of the cause.
Our mission
Our primary mission is to fight the HIV/AIDS epidemic by funding organizations based and operating in Quebec, using a community-based, service-oriented approach.
Our shared vision of the HIV/AIDS movement in Quebec is based on solidarity and commitment, two values that are central to our work. Our working approach is based on cooperation, solidarity and taking into account the needs and realities of people affected by HIV.
We work closely with members of our community to educate the public, raise awareness and change the public’s view of the disease, because we believe that prevention, education and information are powerful tools for tackling the challenges of HIV.
Our values
Solidarity
Our member organizations benefit from the donations of thousands of regular donors who share the same cause.
Engagement
We are committed to the fight against HIV/AIDS by providing financial support to our member organizations, delivering direct services to people living with HIV and their families.
Integrity
Respect for the integrity and dignity of the people we support is a fundamental value of our Foundation.
Horizon 2030
Our Foundation, following the initiative launched by UNAIDS, is committed to implement measures with the aim of halting the HIV epidemic by 2030, in particular by reaching the targets set by the “95-95-95” Response Acceleration Plan:
95% of people living with HIV know their serostatus
95% of all HIV-infected people receive sustainable antiretroviral treatment
95% of people receiving antiretroviral treatment should have their viral load permanently suppressed
